Biovica International AB (OSTO:BIOVIC B) Total Equity : kr136.03 Mil (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Total Equity?

Biovica International AB's total equity for the quarter that ended in Jan. 2024 was kr136.03 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Biovica International AB Total Equity Historical Data

The historical data trend for Biovica International AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Total Equity Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Total Equity

Get a 7-Day Free Trial

52.10

78.22

182.66

124.09

138.64

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Equity	Get a 7-Day Free Trial															176.41	138.64	106.48	81.01	136.03

Biovica International AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biovica International AB's Total Equity for the fiscal year that ended in Apr. 2023 is calculated as

Total Equity	=	Total Assets(Q: Apr. 2023 )	-	Total Liabilities(Q: Apr. 2023 )
	=	172.288	-	33.652
	=	138.64

Biovica International AB's Total Equity for the quarter that ended in Jan. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jan. 2024 )	-	Total Liabilities(Q: Jan. 2024 )
	=	158.32	-	22.29
	=	136.03

Biovica International AB Total Equity Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines